Article
Nischarin expression may have differing roles in male and female melanoma patients
2022-08-04
Abstract excerpt
<title>Abstract</title> <p> Due to the development of resistance to previously effective therapies, there is a constant need for novel treatment modalities for metastatic melanoma. Nischarin (NISCH) is a druggable scaffolding protein reported as a tumor suppressor and a positive prognostic marker in breast and ovarian cancers through regulation of cancer cell survival, motility and invasion. The aim of this stud...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 89c822c7-ec62-5c86-bd38-e20ab1d8606a
- DOI
- 10.21203/rs.3.rs-1576440/v2
